Natrium Fusidat Essential Pharma (Fusidic Acid)

Fusidic Acid, the active ingredient in Natrium Fusidat Essential Pharma, is an antibiotic presented as an intravenous formulation for intravenous use. It treats severe skin and soft‑tissue infections caused by Staphylococcus aureus and other serious bacterial infections where fusidic acid is indicated.

GNH USA supplies Natrium Fusidat Essential Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Fusidic Acid is an antibacterial agent used for infections caused by susceptible Gram‑positive bacteria, particularly Staphylococcus aureus.

Severe skin and soft‑tissue infections: provides antibacterial activity to reduce infection and promote healing. Bone and joint infections: helps eradicate the pathogen in osteomyelitis or septic arthritis. Prosthetic device‑related infections: assists in controlling bacterial colonisation on implanted material.

Fusidic Acid may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Redness or swelling: local inflammatory response. - Fever: transient rise in body temperature. - Nausea: mild gastrointestinal upset. - Diarrhoea: loose stools during therapy. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Liver enzyme elevation: potential hepatotoxicity indicated by raised ALT/AST. - Severe neutropenia: marked reduction in neutrophil count. - Stevens‑Johnson syndrome: rare severe skin reaction. - Renal impairment: worsening kidney function in susceptible patients. - Thrombophlebitis: inflammation of the vein used for infusion.

Before initiating therapy, clinicians should assess patient‑specific factors and monitor for adverse events.

Renal impairment: adjust monitoring and consider dose modification. Hepatic dysfunction: monitor liver enzymes regularly. Known hypersensitivity to fusidic acid: avoid use. Concurrent use with other antibiotics: assess for additive toxicity or antagonism. Pregnancy and lactation: use only if benefit outweighs potential risk. Store at ambient temperature: keep in original container, protect from light and moisture.

Fusidic Acid can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Cyclosporine: increased risk of nephrotoxicity. - High‑dose penicillins: antagonistic antibacterial effect.

Moderate Interactions (Monitor Closely): - Macrolides: potential additive hepatotoxicity. - Warfarin: may increase INR and bleeding risk. - Oral contraceptives: possible reduction in contraceptive efficacy.